Lv42
594 积分 2023-08-01 加入
Targeting peripheral 5-HT2AR enhances antitumor immunity in colorectal cancer
1天前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
16天前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
Antibody-drug conjugates in oncology: A spotlight on overcoming resistance
1个月前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
1个月前
已完结
Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates
1个月前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
3个月前
已完结
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
3个月前
已关闭
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
3个月前
已关闭
T-cell-engaging bispecific antibodies in cancer
5个月前
已完结
皖公网安备34019202002308
